Filing metadata

Accession number
0000899243-21-045265
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Nov 18, 2021
Reporting period
Nov 18, 2021
Description
Insider transaction

Explore SEC Filings Hub